Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRTX | AMGN | BMY | GILD | REGN |
| Company | Vertex Pharmaceutic | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 454.17 | 282.17 | 59.18 | 96.73 | 677.29 |
| High | 472.04 | 286.69 | 60.23 | 98.36 | 688.00 |
| Low | 447.20 | 281.98 | 58.67 | 96.43 | 671.96 |
| Last | 461.68 | 285.42 | 58.95 | 97.20 | 672.98 |
| Change | +23.28 | +1.40 | -0.19 | +0.25 | -10.10 |
| % Change | +5.31% | +0.49% | -0.32% | +0.26% | -1.48% |
| Volume | 3,648,800 | 3,800,300 | 11,345,301 | 9,419,600 | 943,900 |
| 20-Day Average Volume | 1,586,965 | 3,064,475 | 9,732,240 | 6,840,035 | 888,390 |
| Previous Close | 438.40 | 284.02 | 59.14 | 96.95 | 683.08 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 424.75 | 271.56 | 57.45 | 92.60 | 697.45 |
| 20-Day Raw Stochastic | 86.15% | 95.72% | 65.82% | 88.11% | 8.74% |
| 20-Day Relative Strength | 61.04% | 58.76% | 56.59% | 63.92% | 37.25% |
| Weighted Alpha | +6.89 | -11.09 | +27.13 | +35.21 | -36.64 |
| Today's Opinion | 24% Sell | 56% Sell | 88% Buy | 100% Buy | 100% Sell |
| Previous Opinion | 64% Sell | 56% Sell | 88% Buy | 100% Buy | 100% Sell |
| Last Month's Opinion | 72% Sell | 88% Sell | 56% Buy | 88% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.02% since 01/24/25 | +3.63% since 01/24/25 | -1.21% since 01/24/25 | +4.44% since 01/24/25 | -0.42% since 01/24/25 |
| Low | 430.81 on 01/29/25 | 276.18 on 01/27/25 | 58.58 on 01/30/25 | 93.10 on 01/27/25 | 671.96 on 01/31/25 |
| High | 472.04 on 01/31/25 | 286.69 on 01/31/25 | 61.10 on 01/27/25 | 98.36 on 01/31/25 | 698.45 on 01/27/25 |
| 1-Month | |||||
| %Chg | +14.65% since 12/31/24 | +9.51% since 12/31/24 | +4.23% since 12/31/24 | +5.23% since 12/31/24 | -5.52% since 12/31/24 |
| Low | 397.24 on 01/13/25 | 257.05 on 01/06/25 | 54.81 on 01/13/25 | 88.57 on 01/10/25 | 666.25 on 01/13/25 |
| High | 472.04 on 01/31/25 | 286.69 on 01/31/25 | 61.10 on 01/27/25 | 98.36 on 01/31/25 | 743.28 on 01/08/25 |
| 3-Month | |||||
| %Chg | -3.00% since 10/31/24 | -10.85% since 10/31/24 | +5.70% since 10/31/24 | +9.43% since 10/31/24 | -19.71% since 10/31/24 |
| Low | 377.85 on 12/19/24 | 253.30 on 12/19/24 | 53.97 on 11/08/24 | 86.08 on 11/19/24 | 666.25 on 01/13/25 |
| High | 519.88 on 11/08/24 | 328.25 on 11/08/24 | 61.10 on 01/27/25 | 98.90 on 11/11/24 | 862.00 on 11/01/24 |
| 6-Month | |||||
| %Chg | -6.87% since 07/31/24 | -14.15% since 07/31/24 | +23.95% since 07/31/24 | +27.79% since 07/31/24 | -37.64% since 07/31/24 |
| Low | 377.85 on 12/19/24 | 253.30 on 12/19/24 | 46.22 on 08/08/24 | 72.43 on 08/12/24 | 666.25 on 01/13/25 |
| High | 519.88 on 11/08/24 | 340.89 on 08/01/24 | 61.10 on 01/27/25 | 98.90 on 11/11/24 | 1,211.20 on 08/27/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 118,895,984 | 153,422,688 | 119,561,040 | 121,137,048 | 73,953,768 |
| Shares Outstanding, K | 257,529 | 537,533 | 2,028,177 | 1,246,266 | 109,890 |
| Annual Sales | 9,869,200,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | 3,619,600,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 2,771,900,000 | 8,503,000,000 | 11,892,000,000 | 7,545,000,000 | 3,720,700,000 |
| Last Quarter Net Income | 1,045,400,000 | 2,830,000,000 | 1,211,000,000 | 1,253,000,000 | 1,340,600,000 |
| 60-Month Beta | 0.40 | 0.56 | 0.45 | 0.18 | 0.10 |
| Per-Share Information | |||||
| Most Recent Earnings | 4.38 on 11/04/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 | 12.46 on 10/31/24 |
| Latest Earnings Date | 02/10/25 | 02/04/25 | 02/06/25 | 02/11/25 | 02/04/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.620 on 01/03/25 | 0.770 on 12/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | 12/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.78 | 50.55 | 21.88 | 17.09 |